EUVIMEDEUVIMED entdecken
Crossref

Clinical Evaluation of Kataphaladi Churna in Children with Kaphaja Kasa : An Analysis of a Treatment Group from a Clinical Study

Dr.Vinanti Patil (Hasabe), Dr. Mahesh Patil

Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda · 01.10.2026 · 3 (4) · 46

DOI: 10.64522/v4i3.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda, online erschienen am 01.10.2026. Verfasst von Dr.Vinanti Patil (Hasabe) und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background – Kasa is a frequently encountered respiratory complaint during childhood. Ayurveda describes Kaphaja Kasa as a condition predominantly associated with Kapha dosha and characterized by cough, excessive sputum production and associated symptoms. Kataphaladi Churna is a classical Ayurvedic formulation described for respiratory disorders and contains Katphala, Pushkaramula, Pippali and Karkatashrungi. Aim – To clinically evaluate the effect of Kataphaladi Churna in children suffering from Kaphaja Kasa. Materials and Methods – A clinical study was conducted in 36 children aged 6–10 years presenting with classical features of Kaphaja Kasa. Kataphaladi Churna was administered orally twice daily for 7 days, with Madhu as anupana. The dose was calculated according to age. Clinical assessment was performed using subjective parameters including Kasa Vega, Sthivana, Aruchi, Shirashula and Pratishyaya, along with objective parameters including throat redness, crepitations and wheezing. Assessment was performed before treatment and during follow-up on the 3rd, 5th and 7th days. Intra-group statistical analysis was performed using the Wilcoxon signed-rank test for ordinal parameters and McNemar chi-square test for categorical clinical findings. Results – Significant improvement was observed in all assessed subjective parameters following treatment. The percentage improvement was 86.57% in Kasa Vega, 87.96% in Sthivana, 91.90% in Aruchi, 85.65% in Shirashula and 85.65% in Pratishyaya. Improvement was also observed in objective parameters, with 82.35% improvement in throat redness, 82.14% in crepitations and 81.48% in wheezing. The overall mean percentage improvement across the assessed parameters was 85.46%. At the end of treatment, 31 of 36 children (86.11%) showed marked improvement and 5 children (13.89%) showed moderate improvement. Conclusion – Kataphaladi Churna demonstrated substantial clinical improvement in children with Kaphaja Kasa over a 7-day treatment period. The findings support its potential usefulness in the Ayurvedic management of uncomplicated Kaphaja Kasa in children.

Zitieren

APA

(Hasabe), D. P., & Patil, D. M. (2026). Clinical Evaluation of Kataphaladi Churna in Children with Kaphaja Kasa : An Analysis of a Treatment Group from a Clinical Study. Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda, 3(4), 46. https://doi.org/10.64522/v4i3.7

Vancouver

(Hasabe) DP, Patil DM. Clinical Evaluation of Kataphaladi Churna in Children with Kaphaja Kasa : An Analysis of a Treatment Group from a Clinical Study. Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda. 2026;3(4):46. doi:10.64522/v4i3.7

BibTeX
@article{Hasabe2026,
  author = {(Hasabe), Dr.Vinanti Patil and Patil, Dr. Mahesh},
  title = {Clinical Evaluation of Kataphaladi Churna in Children with Kaphaja Kasa : An Analysis of a Treatment Group from a Clinical Study},
  journal = {Vidyapharma : Peer Reviewed Journal for Pharmaceutical, Chemical Sciences and Ayurveda},
  year = {2026},
  volume = {3},
  number = {4},
  pages = {46},
  doi = {10.64522/v4i3.7}
}
Kostenlos starten →